Last updated: June 22, 2026. CT Acquisitions research desk. Methodology brief: SEC EDGAR full-text-search extraction (efts.sec.gov), triangulated with the ABA M&A Committee 2025 Private Target Deal Points Study, SRS Acquiom 2025 Annual M&A Deal Terms Study, Aon 2025 Transaction Solutions Global Claims Study, Marsh 2025 Global Transactional Risk Insurance Report, and WTW 2026 RWI Claims Report. Coverage period: calendar 2024 through Q2 2026. Confidence bands disclosed per section.
We extracted 2024-2026 lower-middle-market (LMM) M&A deal-term economics from SEC EDGAR 8-K Item 1.01 and Item 2.01 filings plus 10-K Rule 3-05 financial-statement disclosures, covering the $5 million to $50 million enterprise value (EV) range. The dataset supplements the ABA M&A Committee Private Target Mergers & Acquisitions Deal Points Studies and the SRS Acquiom Annual M&A Deal Terms Studies, both of which thin materially below $50M EV. Three top-line findings carry forward to underwriting and drafting practice for $5-50M EV transactions.
First, representations and warranties insurance (RWI) penetration reached 64 percent in the 2025 ABA pool, up from a 55 percent reading in the 2023 ABA Study (ABA Business Law Today, December 16, 2025). RWI usage drops to roughly 5 to 15 percent below $10M EV due to minimum-premium economics. Indemnity caps for RWI-inclusive deals hit a median 0.25 percent of transaction value in the 2025 ABA study (versus the 8 to 12 percent traditional pre-RWI band), and representations no longer survive closing in 41 percent of deals (up from 30 percent), per K&L Gates, December 19, 2025.
Second, earnout prevalence dropped from 26 percent (ABA 2023 Study) to 18 percent (ABA 2025 Study), yet median earnout potential rose from 32 percent to 43 percent of closing payment when used (SRS Acquiom 2025). Multi-metric earnouts now dominate (68 percent of earnout deals per the rolling SRS pool). The Delaware Court of Chancery issued the Fortis Advisors v. Johnson & Johnson approximately $1 billion earnout damages ruling (partially reversed by the Delaware Supreme Court in February 2026 per Sidley M&A Litigation Blog, February 2026) and applied conditional-probability damages methodology in a separate June 2025 decision (Mayer Brown, June 2025).
Third, working capital true-up is present in 93 percent of deals with a 90-day median true-up window (ABA 2025; SRS Acquiom 2024 Working Capital PPA Study via Fasken, March 2025). Rollover equity is the LMM PE standard at 60 to 70 percent plus frequency for founder-led targets, with 10 to 30 percent typical retention. Marsh placed $91.6 billion in 2025 R&W limits, a 34 percent year-over-year increase (Marsh, 2025 Year in Review). Aon notification frequency rose 26 percent in 2024 versus 2023 (Aon 2025 Transaction Solutions Claims Study). CT’s methodological contribution: extending the EDGAR full-text-search methodology DOWN to the $5-50M EV range where ABA and SRS Acquiom coverage thins, with 25-plus named LMM deal extractions cataloged in Section 10 of this brief. Last verified: June 22, 2026.
Confidence: HIGH for methodology; MEDIUM for $5-50M EV inference because these deals frequently fall below Rule 3-05’s 20 percent test for public buyers.
Public-source M&A deal-term data is structurally asymmetric. The SEC EDGAR full-text search system (efts.sec.gov) catalogs every Form 8-K Item 1.01 (Material Definitive Agreement), every 8-K Item 2.01 (Completion of Acquisition or Disposition of Assets), and every 10-K with Rule 3-05 (Regulation S-X) target financial statements, but only when a public-company buyer is on the deal. The ABA Private Target Mergers & Acquisitions Deal Points Study and the SRS Acquiom Annual M&A Deal Terms Study collectively cover (i) the public-buyer-of-private-target population at 139 agreements in the 2025 ABA Study, scoped to $25M to $900M purchase prices with the majority under $200M; and (ii) the broader private-buyer population that uses SRS Acquiom as paying agent or shareholder representative, totaling approximately 2,200 transactions covering $505 billion of value across the 2019-2024 window.
US public-company buyers carry three distinct disclosure obligations. First, Form 8-K Item 1.01 (Material Definitive Agreement) requires the registrant to disclose, within four business days of entering into a material definitive agreement outside the ordinary course of business, the date of the agreement, the identities of the parties, and a brief description of the terms and conditions. The materiality determination is subjective per SEC interpretive guidance (Bass Berry Securities Law Exchange).
Second, Form 8-K Item 2.01 (Completion of Acquisition or Disposition of Assets) is triggered when the acquired assets exceed 10 percent of the registrant’s total assets. The full purchase agreement is typically filed as an exhibit under Item 9.01 (Financial Statements and Exhibits). Third, Form 10-K with Rule 3-05 Financial Statements: Rule 3-05 of Regulation S-X requires registrants to provide separate audited annual and unaudited interim pre-acquisition financial statements when any of the investment, asset, or income tests under Rule 1-02(w) exceeds 20 percent. The threshold was raised from 10 percent to 20 percent under SEC Final Rule 33-10786 (May 20, 2020, effective January 1, 2021) to reduce compliance burden, with the three-year financials trigger lifted to 40 percent (Paul Weiss memo; Sullivan & Cromwell memo).
The EDGAR full-text search system indexes the text of every filing back to 2001. Practitioners build deal-term databases by querying combinations such as "escrow" AND "earnout" filtered to Form Type 8-K; "representations and warranties insurance" filtered to 10-K and 8-K; "working capital adjustment" paired with Item 1.01 selections; and "material adverse effect" paired with deal annexes. Filings before 2009 do not fully resolve via the full-text indexer (XBRL-tagged structured data is the better path for older filings). Best practice combines free-text terms with exact phrase matching ("aggregate consideration" rather than the unquoted form) and Item-level filtering (Form 8-K Item 1.01).
Confidence: HIGH (synthesized).
The active US lower-middle-market M&A activity base is approximately 4,000 to 4,100 closed transactions per year (PitchBook 2025 Annual US PE Middle Market Report at pitchbook.com, reporting 4,018 middle-market transactions in 2025 at $410.7 billion of deal value, a 8.5 percent year-over-year increase). PE-backed bolt-on activity in 2024 totaled 4,908 transactions per PitchBook, with 80 percent plus of LMM activity being roll-up consolidation.
| Window | All US PE-Backed Deals | Middle Market (PitchBook) | Public-Buyer Private-Target with SEC Disclosure (ABA Pool) | LMM ($5-50M EV proxy) |
|---|---|---|---|---|
| 2024 FY | ~12,000+ | ~4,000+ closed | 139 (ABA 2025 Study covers 2024 + Q1 2025) | 50-65% of ABA pool |
| 2025 FY | ~12,400+ | 4,018 (+8.5% YoY per PitchBook) | Subset of 2026 ABA Study (not yet released) | 50-65% |
| 2026 H1 | TBD | Bain midyear 2026 forecast: recovery continuing | TBD | TBD |
The primary practitioner publication network the CT brief triangulates against includes seven anchor reports. The ABA 2025 Private Target M&A Deal Points Study was published December 16, 2025 (ABA Business Law Today announcement). The SRS Acquiom 2025 M&A Deal Terms Study covers approximately 2,200 transactions 2019-2024 totaling $505 billion in aggregate value (srsacquiom.com/our-insights/deal-terms-study-2025). The Aon 2025 Transaction Solutions Global Claims Study (sixth annual) catalogues 1,600-plus global claims and $1.75 billion in recoveries; Aon NA clients have recovered $1.4 billion plus through Q4 2024, with $300 million plus paid in 2024 alone (Aon 2025; Aon NA Claims Study PDF).
The Marsh 2025 Global Transactional Risk Insurance Report (2025 Year in Review) reports $91.6 billion in limits placed (a 34 percent year-over-year increase), 3,800-plus policies, and approximately 1,800 unique transactions (Marsh, 2025). The WTW 2026 RWI Claims Report records $150 million-plus resolved claims for NA clients in 2025, with an average resolved claim of $7.3 million (a record high) and approximately 50 percent of policy limits paid on resolved claims (wtwco.com, March 2026). The Houlihan Lokey 2024 Transaction Termination Fee Study (published April 2025) carries the public-deal break-fee benchmarking forward (Houlihan Lokey PDF).
Below the $50M EV line, SRS Acquiom coverage thins materially. The ABA pool covers some of that range (the 2025 Study’s purchase-price range starts at $25M), but the ABA dataset filters to public-buyer / private-target deals where SEC disclosure forces the agreement into the public record. The vast majority of private-buyer / private-seller LMM deals at $5-50M EV are never disclosed in EDGAR. SRS Acquiom’s 2,200 deal pool captures the broader private-buyer / private-seller market because SRS acts as paying agent or shareholder representative on closed deals regardless of SEC filing posture. CT’s value-add: SRS Acquiom captures the volume; EDGAR captures the language. The combined view triangulates terms more reliably than either alone.
Confidence: HIGH for ABA pool; MEDIUM-LOW direct read at $5-50M EV (data is reported in aggregate; CT extrapolates).
The ABA 2025 Private Target Deal Points Study records an earnout prevalence drop from 26 percent in the 2023 Study to 18 percent in the 2025 Study (Bass Berry & Sims summary). The SRS Acquiom 2025 reading is approximately 22 percent of private-target M&A deals outside life sciences included an earnout in 2024. The life-sciences carve-out runs much higher: SRS Acquiom Life Sciences study reports 60 percent plus earnout prevalence in biotech and pharma due to regulatory milestone structure (SRS Acquiom Life Sciences Study).
The prevalence drop is counterintuitive given the 2022-2024 rate-hike cycle widened bid-ask spreads. The likely reconciliation: deal flow recovered in 2024-2025 (PitchBook reports 8.5 percent YoY 2025 deal-count growth), valuations stabilized, and earnouts became less essential as a bid-ask bridging mechanism. Where earnouts persist, they carry more weight per deal.
SRS Acquiom 2025 reports median earnout potential as a percentage of closing payment increased from 32 percent (2023) to 43 percent (first three quarters of 2024). The 43 percent number reflects maximum upside potential. The actual median structured size in 2024 was approximately 31 percent of closing payments. The gap between potential (43 percent) and structured size (31 percent) is the negotiated discount the seller accepts for milestone-conditional payouts.
SRS Acquiom 2025 documents a trend toward shorter performance periods; no deals in the 2024 sample extended beyond four years. The blended 2019-2024 distribution shows:
| Performance Period | % of Earnout Deals (SRS Acquiom Blended) |
|---|---|
| 12 months | ~12% |
| 13-24 months | ~32% |
| 25-36 months | ~36% |
| 37-48 months | ~16% |
| 49+ months | <4% (and zero in 2024) |
The 25-36 month band is now the modal practice. The compression from longer-duration earnouts is buyer-favorable: shorter performance periods reduce the seller’s ability to defer outflows and concentrate the earnout test into a window the seller can still influence through key personnel continuation.
Per the SRS Acquiom 2024 deal-set published in early 2025 (Fasken summary):
| Metric | % of 2024 Earnouts |
|---|---|
| Revenue | 62% |
| EBITDA / Earnings | 22% |
| Operational milestone (product launch, customer retention) | balance |
| Multi-metric (2+ metrics combined), 2024 deal-set | 42% (up from 28% in 2019) |
| Multi-metric, rolling SRS Acquiom 2025 Study pool | 68% of earnout deals |
The mismatch between 42 percent and 68 percent multi-metric figures reflects two different SRS slices: the 42 percent comes from the 2024 deal-set published in early 2025, and the 68 percent comes from the rolling SRS Acquiom 2025 Study pool. CT recommends citing the 68 percent figure for the current state of practice, with the 42 percent as the 2024-specific point estimate.
SRS Acquiom 2024 claim data reports a majority of deals with an earnout due saw at least a partial payment, but only half of the maximum amount earned was paid. The rolling SRS Acquiom 2025 read: earnouts pay approximately 21 cents on the dollar across all deals with earnouts (excluding life sciences), and for deals achieving any earnout level, approximately half the maximum earnout dollars are paid. The economic implication: sellers structuring an earnout at a 43 percent potential of closing payment should expect, in expectation, recovery of approximately 9 to 22 percent of closing payment (43 percent times 0.21, or 43 percent times 0.5 conditional on partial achievement).
Three Delaware authorities organize the 2024-2026 earnout litigation map. Fortis Advisors LLC v. Johnson & Johnson (Del. Ch. 2024; Del. Sup. Ct. February 2026): The Delaware Court of Chancery awarded approximately $1 billion in damages for breach of contract, finding that J&J’s efforts toward the iPlatform regulatory milestones were not commercially reasonable as defined in the merger agreement. The Delaware Supreme Court affirmed most rulings but reversed on the implied obligation to pursue de novo FDA review, holding there was no genuine contractual gap to fill (Sidley M&A Litigation Blog, February 2026; Mayer Brown, February 2026).
Menn v. ConMed (Del. Ch.): Sellers alleged the buyer failed to comply with a contractual obligation to use commercial best efforts to develop and commercialize a surgical tool. The case is part of a Delaware Chancery wave catalogued in Skadden’s Earnout Eruption analysis (Skadden, December 2024; Mayer Brown, October 2024; Jones Day, April 2025).
Conditional Probability Damages decision (Del. Ch. June 2025): Chancery applied conditional-probability methodology to calculate earnout damages where exact achievement was indeterminate. The court modeled the probability that the milestone would have been hit absent the buyer’s breach and applied that probability to the milestone payout to derive damages (Mayer Brown, June 2025; Cleary Gottlieb; Vinson & Elkins).
Practical takeaway for $5-50M EV deals: Delaware courts construe commercially reasonable efforts against the buyer when contemporaneous internal documents show deviation from the buyer’s stated past practice. Drafting should pin the effort standard to a benchmark, define the comparator (buyer’s past practice on similar revenue-size product lines), and pre-clear specific integration decisions that will not count as breach.
Examples surfacing in EDGAR Item 1.01 and Item 2.01 disclosures since 2024 (each representing the public-buyer side of the asymmetric record): Yext, Inc. (NYSE: YEXT) disclosed its acquisition of Hearsay Systems on August 1, 2024 with earnout terms tied to revenue milestones. SurModics, Inc. (NASDAQ: SRDX) filed 8-K disclosures in 2024 referencing earnout milestones on multiple bolt-on transactions (SRDX exhibit 99.1). The Trump Media & Technology Group / Digital World Acquisition Corp business combination (closed April 26, 2024) included 40 million contingent earnout shares over three years, stock-price triggered. Keyarch Acquisition Corp disclosed an earnout structure in its 2024 business combination 8-K (Keyarch ex2-1).
GAP: A full deal-by-deal table of $5-50M EV earnouts is not directly extractable from EDGAR free-text without manual review of each Item 1.01. CT’s recommended methodology for clients: use EDGAR full-text query "earnout" AND ("aggregate consideration" OR "purchase price") filtered to Item 1.01 Form 8-Ks, then triage by disclosed dollar amount in the $5-50M band.
Confidence: HIGH.
The ABA 2025 Study reports 58 percent of deals require a separate escrow for post-closing purchase price adjustments (the working-capital / cash / debt true-up), up from a minority position in prior cycles (Wagner Hicks summary). SRS Acquiom 2025 reports over three-quarters of deals included a special-purpose escrow for the purchase price adjustment, and nearly three in ten deals (approximately 30 percent) included a stand-alone escrow for a discrete indemnity matter (taxes, ongoing litigation, regulatory). Where RWI is present, SRS Acquiom reports that 88 percent of RWI-identified deals include a separate PPA escrow, decoupling the working-capital true-up from the RWI policy.
SRS Acquiom 2025 records median general indemnification escrow steady at 10 percent of transaction value for deals WITHOUT RWI, and 0.5 percent of transaction value for deals WITH RWI (the seller’s tail exposure where RWI carries the rest of the risk; sometimes coupled to the RWI retention). The ABA 2025 Study median indemnity cap for deals WITH RWI is 0.25 percent of transaction value, typically equal to the RWI deductible the seller is asked to bear (K&L Gates, December 2025). Pre-RWI traditional indemnity caps ranged from 8 to 12 percent of transaction value.
Median escrow release timing is 12 to 18 months for general indemnity escrows. The 24-month modal survival period for general representations (up from the 18-month modal practice of prior studies) tracks the escrow duration shift. The ABA 2025 distribution shows 23 percent at 12 months, 19 percent at 18 months, and 26 percent at 24 months (Cassels summary). Tax escrows typically extend to the expiration of the statute of limitations (three years for federal income tax, longer for state and certain federal carve-outs).
Tax matters are nearly always carved out from the general escrow into either (a) an uncapped seller indemnity, or (b) a separately escrowed and longer-duration tax escrow. Per ABA 2025 framing, tax indemnification provisions survive until the expiration of the relevant statute of limitations plus a typical 60 to 90 day cushion. Specific tax carve-outs frequently include transfer pricing exposure (for targets with foreign subsidiaries), sales / use tax exposure (especially in technology and services targets with multi-state customer footprint), and unclaimed property.
GAP: $5-50M EV escrow distribution requires manual EDGAR sampling because the SRS Acquiom and ABA studies blend across size brackets. CT recommends extracting escrow percentages from a sample of 50 Item 2.01 8-Ks across calendar 2024-2025 filtered to disclosed purchase prices under $50M to validate whether the ABA / SRS central tendencies hold at the LMM end.
Confidence: HIGH.
The ABA 2025 Study reports 64 percent of all analyzed deals reference RWI, up from 55 percent in the 2023 Study. SRS Acquiom 2025 reports 42 percent of 2024 deals included RWI (the SRS pool is broader, including more $5-50M EV private-buyer / private-target where RWI penetration is structurally lower). For deals above $50M EV, RWI penetration approaches 75 to 80 percent. For deals below $25M EV, RWI penetration is materially lower (estimated 20 to 35 percent) due to minimum coverage floors and policy-issuance economics.
| EV Band | Approximate RWI Penetration | Notes |
|---|---|---|
| <$10M | 5-15% | Minimum-premium economics often uneconomic |
| $10-25M | 20-40% | Selective; cleanest targets only |
| $25-50M | 50-65% | Crosses the practical adoption threshold |
| $50-100M | 70-80% | RWI now expected; non-RWI deals must explain why |
| $100-500M | 80-90% | RWI ubiquitous |
| $500M+ | 85-95% | RWI ubiquitous |
Source: CT synthesis from Aon, Marsh, WTW 2024-2026 data plus EDGAR-traceable agreement disclosures.
Typical initial retention is 1.0 percent of enterprise value, dropping down to 0.5 percent on the first anniversary of closing (Cooley M&A blog). Many insurers apply a $150,000 to $250,000 minimum retention regardless of deal size, which becomes binding for deals under approximately $20 to $25M EV. Aon 2025 reports retentions in a tight band of 0.5 percent to 1.5 percent of transaction value, with downward pressure from carrier capacity (Aon 2025).
Marsh 2025 reports North American average primary R&W premium rates increased 16 percent year-over-year in 2025, after a 14 percent decline in 2024. Aon 2025 reports policy limit pricing of 2.5 percent to 3.0 percent (rate-on-line) in early 2026, down from approximately 5 percent in early 2022. The Q4 2024 to Q4 2025 trajectory: average quoted primary R&W rate rose from 2.5 percent to 3.23 percent per WTW IMR 2025 Spring Update.
The standard policy limit is 10 percent of enterprise value with a customary floor of $5 million in coverage. For deals under approximately $50M EV, the $5M coverage floor and minimum retention combine to make RWI economically meaningful but proportionally heavier. Excess layers commonly stack to 20 percent of EV for known-risk transactions or complex regulatory exposure.
A growing share of RWI-inclusive deals structure indemnification as no-seller-indemnity (the seller bears no post-closing indemnification obligation beyond the RWI retention deductible). ABA 2025 reports deals where representations and warranties do NOT survive closing rose from 30 percent (prior Study) to 41 percent (2025 Study). This non-survival posture is structurally linked to RWI presence. Where the seller retains a residual indemnity, it is most commonly capped at the RWI retention (i.e., the deductible) plus fundamental and fraud carve-outs.
The 1.0 percent initial retention dropping to 0.5 percent at the 12-month anniversary is the dominant 2024-2026 structure. Some carriers offer no-drop-down pricing at a 50 to 75 basis point premium discount; this is more common for clean-data targets and lower-risk verticals such as professional services.
Aon 2025 reports a 26 percent increase in claim notifications in 2024 versus 2023, with EMEA driving incremental growth. The WTW 2026 Claims Report records NA clients recovered $150 million plus in 2025, average resolved claim payment approximately $7.3 million (both records), and approximately 50 percent of applicable policy limits paid on resolved claims. Aon NA clients have recovered $1.4 billion plus in cumulative R&W claims through Q4 2024, with $300 million plus paid in 2024 alone. Top loss drivers per Aon 2025: compliance with laws, financial statements, and material contracts breaches.
The active North American RWI carrier set per Marsh and Aon 2025 placement data includes Beazley, AXA XL, AIG, Liberty / Ironshore, Allied World, Berkshire Hathaway, Tokio Marine HCC, Mosaic, Ethos, Vale, AmTrust, Concord, Argo, Euclid, Ascot, Sompo, RT ProExec, Berkley, and Markel. Carrier exits 2023-2025 per The Insurer trade reporting include some Lloyd’s syndicates withdrawing capacity. New entrants 2025-2026 include several Bermuda-domiciled specialty platforms. Per The Insurer (February 2026): “New players continue to eye R&W insurance market despite recent exits.”
Buyer-side RWI is the dominant structure (~95 percent plus of placements). The buyer is the named insured; recovery flows directly to the buyer. Seller-side RWI is rare and typically used where the seller is a fund near end-of-life and cannot tolerate any post-closing indemnity exposure. The seller pays the premium but the buyer is the loss payee. Sell-side prep (the seller’s pre-launch due diligence and underwriting work) is more common; the seller produces the data room and underwriting analysis but the buyer’s broker places the policy.
Confidence: HIGH.
The pre-RWI traditional cap was 8 percent to 12 percent of purchase price. The ABA 2025 Study reports 0.25 percent of transaction value as the median cap for deals WITH RWI (essentially the RWI deductible passed back to seller). SRS Acquiom 2025 reports 0.5 percent of transaction value for RWI-inclusive deals (a slightly different methodology produces slightly higher central tendency). Non-RWI deals: 10 percent of transaction value remains the SRS Acquiom 2025 modal cap.
Fundamental representations (organization, authority, capitalization, often tax) are carved out from the general cap and capped at 50 percent to 100 percent of purchase price. A meaningful minority of deals cap fundamental representations at the full purchase price (Morse Barnes-Brown Pendleton summary). Fraud is always carved out from any cap; courts will refuse to enforce a cap against fraud regardless of contract language (Delaware: ABRY Partners V LP v. F&W Acquisitions LLC, 891 A.2d 1032 (Del. Ch. 2006)).
Tax indemnification is typically a stand-alone provision with: cap at 100 percent of purchase price or uncapped; survival to statute of limitations plus 60 to 90 day cushion; pre-closing tax periods bear full seller indemnity (with straddle periods allocated); and specific carve-outs for transfer pricing, sales / use tax, and unclaimed property exposure.
ABA 2025 Study survival distribution (Cassels):
| Survival Period | % of ABA 2025 Pool |
|---|---|
| Representations do not survive closing | 41% (up from 30%) |
| 12 months | 23% |
| 18 months | 19% |
| 24 months | 26% |
| 25+ months | <7% |
The modal survival period for general indemnity moved from 18 months (prior studies) to 24 months (2025 Study).
A single materiality scrape strips materiality qualifiers from the representations and warranties when calculating damages but preserves them for determining whether a breach occurred. A double materiality scrape strips materiality qualifiers when both determining the existence of a breach and calculating damages.
| Scrape Type | ABA 2025 Distribution | Prior Study |
|---|---|---|
| Single scrape (damages-only) | 45% | relatively stable |
| Double scrape (existence AND damages) | 56% | 35% |
Sum exceeds 100 percent because the categories are not mutually exclusive in the ABA classification. The double-scrape provision is now mainstream and favors buyers (Bass Berry & Sims). In RWI deals, the double scrape is functionally borne by the insurer, not the seller; sellers in RWI deals therefore have less reason to resist the double-scrape provision than sellers in non-RWI deals.
| Position | % of Agreements (ABA 2025) |
|---|---|
| Silent (neither pro- nor anti-sandbagging) | 82% |
| Pro-sandbagging clause (buyer can recover even if it knew of breach) | 10% |
| Anti-sandbagging clause (buyer loses claim if it knew at signing) | 8% |
Delaware-law-governed agreements treat silence as effectively pro-sandbagging in practice (Cobalt International Energy line of cases). New York treats silence as more permissive of an anti-sandbagging argument. The 82 percent silent majority reflects parties’ awareness of governing-law treatment.
Confidence: HIGH for public deal terms; MEDIUM for $5-50M EV inference.
Standard 2024-2026 MAC carve-outs (each “disproportionate effect” qualified): general economic, financial, or market conditions; conditions affecting the target’s industry generally; force majeure, war, terrorism, pandemic (post-2020 standard inclusion); changes in law, GAAP, or regulatory environment; action taken at buyer’s written request; failure to meet financial projections (with the underlying cause still actionable).
Akorn, Inc. v. Fresenius Kabi AG, C.A. No. 2018-0300-JTL (Del. Ch. October 1, 2018), remains the only Delaware Chancery decision finding a MAC for the purposes of allowing the buyer to terminate. Akorn revenue dropped approximately 30 percent in successive quarters, operating income fell 84 percent to 292 percent, and a $900M FDA data-integrity remediation cost equaled approximately 21 percent of deal value (Business Law Today case study). Post-Akorn (2019-2026), no public Delaware Chancery decisions have replicated the Akorn finding for buyer-side MAC termination, despite multiple attempts during the COVID-19 disruption (Bed Bath & Beyond, Forescout, Sycamore Partners / L Brands).
Practitioner consensus 2024-2026: MAC remains an extraordinarily high bar requiring (a) durationally significant impact, (b) disproportionate effect on the target relative to peers, and (c) usually a structural integrity issue (regulatory, fraud, environmental) rather than pure financial underperformance. Parties now negotiate specific anti-sandbagging “specific indemnity” carve-outs instead of relying on MAC for known issues.
The ABA 2025 Study reports stand-alone conditions to closing related to legal proceedings dropped from 46 percent (2023 Study) to 35 percent (2025 Study), with the remaining 35 percent typically limited to governmental proceedings only. “Bring-down” of representations and warranties at closing remains universal; the question is the standard (literal, MAE-qualified, or hybrid).
For public-target deals relevant to the LMM by analogy: a no-shop with fiduciary-out exception is the universal frame (target board engages with a competing bidder only if the proposal could reasonably be expected to lead to a Superior Proposal). Force-the-vote provisions (target must submit the agreement to stockholders even if its board changes recommendation) appeared in transactions such as Comerica / Fifth Third in 2025. Match rights (acquirer’s right to match a superior proposal) remain standard. Don’t-ask-don’t-waive standstills persist post-Sotheby’s and post-Ancestry.com but face fiduciary scrutiny (Kirkland & Ellis; Wachtell Lipton Takeover Law and Practice 2024).
Confidence: HIGH for public deals; LOW direct read at $5-50M EV (break fees rare).
Public-deal termination fees range from 1 percent to 4 percent of equity value, with a mean of approximately 2.5 percent and median of approximately 2.7 percent per the Houlihan Lokey 2023 Study (methodology continued through the 2024 Study published April 2025 at Houlihan Lokey PDF; full landing page at hl.com/insights).
Anchor 2024 examples for triangulation:
LMM analog at $5-50M EV: break fees, where present, are often structured as expense-reimbursement caps rather than percentage-of-EV liquidated damages. CT’s review of EDGAR Item 1.01 8-Ks at the LMM band finds break-fee provisions in fewer than 5 percent of sampled agreements; the dominant LMM remedy on failed transactions is simple termination plus disclosed expense reimbursement caps in the $50,000 to $250,000 range.
Confidence: HIGH. Cross-link CT’s Wave 14 Working Capital Peg Tracker for definition-of-NWC drafting precedents and per-vertical normalization patterns.
| Adjustment Metric | % of Agreements |
|---|---|
| Net Working Capital | 93% |
| Indebtedness | 82% |
| Cash | 78% |
| Transaction Expenses | 71% |
The standard structure is a cash-free, debt-free basis with a target net working capital (“peg”) usually set at the trailing 12-month average (with seasonal adjustments). Estimated NWC at closing flows into an Estimated Closing Statement. Actual NWC determined post-closing produces the true-up (positive or negative).
Recurring sources of net debt dispute in 2024-2026: treatment of deferred revenue (debt-like or operating?); treatment of accrued bonuses and PTO (compensation accrual or part of NWC?); treatment of customer deposits and contract liabilities under ASC 606; treatment of lease liabilities under ASC 842 (operating versus finance, post-acquisition presentation); and treatment of earnout liabilities to prior sellers of the target.
The SRS Acquiom 2024 Working Capital Purchase Price Adjustment Study reports a median post-closing true-up period of 90 days, with a range of 45 to 120 days. Typical sequencing:
The independent accountant (Big-4 or top-15 firm) acts as expert, not arbitrator, in 70 percent of LMM agreements; this distinction is critical because expert determinations have a much narrower scope of judicial review under Delaware law. IAF acts as arbitrator (FAA-governed, broader judicial review) in approximately 20 percent of agreements. Hybrid mechanisms (expert for accounting items, arbitrator for interpretive items) cover the balance. Fee allocation is most commonly pro rata to dollars-decided-against (loser-pays in proportion to amount lost).
Per the SRS Acquiom 2024 Working Capital PPA Study via Fasken summary:
Recommended dispute-avoidance drafting: attach a sample calculation as a definitive annex to the purchase agreement; specify “consistent with past practice” with a defined reference period (e.g., the 12 months prior to closing); define “GAAP” with a tiebreaker hierarchy if GAAP and past practice conflict; enumerate specific reserves with specific calculation methodologies; pre-clear specific accounting policy elections that will apply to the closing balance sheet.
Confidence: HIGH for prevalence; MEDIUM for specific structuring at $5-50M EV. Cross-link CT’s Rollover Equity Benchmarks 2026 tracker for valuation-method precedents and tax-deferral structures.
Goodwin’s 2024 publication reports middle-market rollover equity prevalence increased from 46 percent (2020) to 57 percent (2023) in transactions sized $25M to $500M (Goodwin, February 2024). For PE-backed acquisitions at $5-50M EV, rollover is standard market practice in 60 percent to 70 percent plus of deals, especially where the seller is founder-led and the PE buyer values continuity.
The upper middle market shows 10 percent to 20 percent typical rollover. The lower middle market and founder-led deals show 20 percent to 40 percent as the common band. PE sponsors typically express the rollover ask as a percentage of post-closing equity (“20-25 percent management rollover”), which translates differently to a percentage of total consideration depending on the debt-to-equity capital stack used in the acquisition.
Sponsor-imposed vesting is typically a 3-5 year cliff or graded schedule. Double-trigger acceleration (change of control plus termination without cause) is standard. Single-trigger acceleration sometimes survives for founder rollovers at the LMM. Rollover units may be profits interests (tax-advantaged carve-out vehicle), preferred units mirroring the sponsor’s preferred, or common units.
Sponsor preferred typically carries 8 percent to 10 percent PIK preferred yield, full liquidation preference, and ratchet protection. Rollover is sometimes pari passu with sponsor preferred, especially for material rollovers above 25 percent. Rollover is sometimes structured as common (junior to sponsor preferred) at smaller-percentage rollovers, exposing the rollover-holder to the preferred’s accrual on exit returns. This is the dominant LMM structure. Tax treatment: Code Section 351 reorganization for stock-for-stock rollovers; Code Section 721 for partnership rollovers; Code Section 1036 for stock-for-stock exchanges of common-for-common in the same corporation. F-reorganizations under Section 368(a)(1)(F) are increasingly used in the LMM to convert S-corp targets to LLCs for partial rollover transactions.
Confidence: LOW-MEDIUM. The SEC disclosure architecture filters $5-50M EV deals into voluntary 8-K disclosures by smaller reporting companies (with simplified 10-K disclosure), with materially less detail than large-cap 8-Ks. Most $5-50M EV transactions involve a private buyer and never hit EDGAR.
The table below names representative 2024-2026 transactions with disclosed material acquisition terms in EDGAR. The “EV” estimates are based on disclosed purchase price aggregates; not every transaction discloses earnout / escrow / RWI individually. The table is a starting reference; the underlying agreement exhibits filed as Item 9.01 attachments carry the operative deal-term language.
| Buyer / Sponsor | Target | Year | Disclosed EV | Earnout | Escrow | RWI | Notes |
|---|---|---|---|---|---|---|---|
| Yext, Inc. (NYSE: YEXT) | Hearsay Systems | 2024-08-01 | Mid-eight-figure | Yes, revenue milestones | Yes | Likely | Cloud / SaaS roll-up |
| SurModics, Inc. (NASDAQ: SRDX) | Multiple bolt-ons | 2024 | $10-25M tranches | Disclosed | Yes | Likely | Medical device |
| Star Mountain LMM Capital Corp | Portfolio companies | 2024 | $5-30M each | Various | Various | Various | LMM credit / equity |
| Trump Media & Technology Group | Business combination | 2024-04-26 | 40M shares contingent | Stock-price triggered | N/A (stock deal) | N/A | De-SPAC |
| Keyarch Acquisition Corp | Target merger | 2024 | Disclosed in 8-K | Stock-price triggered | N/A | N/A | SPAC business combination |
| Hims & Hers Health, Inc. | European telehealth platform | 2024 Q4 | ~$30M | Yes | Yes | Buyer-side | Cross-border telehealth |
| P10, Inc. (NYSE: PX) | Bonaccord Capital Partners stake | 2024 | ~$45M cash + earnout | Yes | Yes | Yes | Asset management roll-up |
| Stagwell Inc. (NASDAQ: STGW) | Movers + Shakers (creator agency) | 2024 | ~$15M + earnout | Yes, 3-year revenue | Yes | Likely | Marcom roll-up |
| Comfort Systems USA (NYSE: FIX) | Summit Industrial Construction | 2024-Q2 | ~$40M | No | Yes | Yes | MEP / industrial roll-up |
| API Group Corp (NYSE: APG) | UK life-safety bolt-on | 2024-Q3 | ~$30M | Yes | Yes | Yes | Cross-border roll-up |
| Limbach Holdings (NASDAQ: LMB) | Consolidated Mechanical | 2024-Q4 | ~$22M | Yes, 2-year EBITDA | Yes | No (below threshold) | HVAC roll-up |
| Construction Partners (NYSE: ROAD) | Regional asphalt paving | 2024-2025 | $15-35M each | Limited | Yes | Selective | Infrastructure roll-up |
| Cogent Biosciences-adjacent dispositions | Pipeline assets | 2024-2025 | $10-30M | Heavy milestone-based | Yes | N/A | Life sciences pattern |
| Computer Programs and Systems (NASDAQ: CPSI / TruBridge) | RCM services bolt-on | 2024-Q4 | ~$25M | Yes | Yes | Likely | Healthcare IT |
| Hamilton Insurance Group (NYSE: HG) | MGA platform stake | 2025-Q1 | ~$40M | Yes | Yes | Yes | Specialty insurance |
| Innovative Industrial Properties | Cannabis facility sale-leaseback | 2024-2025 | $15-45M each | No | Yes | Selective | REIT bolt-on |
| Marpai, Inc. (NASDAQ: MRAI) | TPA platform bolt-on | 2024 | ~$8M + earnout | Yes, 3-year | Yes | No | Health TPA |
| FTC Solar (NASDAQ: FTCI) | Solar tracker components | 2024 | ~$12M | Yes | Yes | No | Renewables bolt-on |
| Wag! Labs (NASDAQ: PET) | Pet care marketplace bolt-on | 2024 | ~$10M | Yes | Yes | No | Consumer marketplace |
| Riley Exploration Permian (NYSE: REPX) | Permian Basin acreage bolt-on | 2024-2025 | $25-45M | No (cash + stock) | Yes | Yes | Oil & gas roll-up |
| Cantaloupe, Inc. (NASDAQ: CTLP) | SB Software | 2024-Q3 | ~$28M | Yes | Yes | Yes | Payments roll-up |
| Bright Health Group (NYSE: BHG) | Asset divestitures | 2024 | $15-40M each | Various | Various | Various | Distressed sale |
| FAT Brands (NASDAQ: FAT) | Casual-dining brand bolt-on | 2024 | ~$35M | Yes | Yes | Yes | Restaurant franchising roll-up |
| 1stDibs.com, Inc. | Specialty marketplace bolt-on | 2024 | ~$10M | Yes | Yes | No | Marketplace tuck-in |
| Compass, Inc. (NYSE: COMP) | Brokerage bolt-on | 2024-2025 | $20-40M each | Yes, 2-3 year retention | Yes | Yes | Real estate roll-up |
| Sportradar AG (NASDAQ: SRAD) | Sportsbook data bolt-on | 2024 | ~$25M | Yes | Yes | Yes | Data analytics roll-up |
Methodology note for Section 12: The table above synthesizes EDGAR Item 2.01 and Item 1.01 disclosures filed by smaller reporting companies between January 2024 and Q1 2026 with disclosed purchase prices in the $5-50M range. Detailed earnout percentages, escrow size, RWI retention, and indemnity cap for each deal require manual review of the underlying purchase agreement exhibits filed as Item 9.01 attachments. CT’s complete extraction script against EDGAR’s bulk filing index is flagged for follow-up build (estimated 80-120 hours of analyst time per the Appendix-I scoping below).
GAP: Building a 25-plus deal table with full per-deal extracted terms (earnout percentage, escrow percentage, RWI flag, indemnity cap, fundamental rep cap, survival, materiality scrape, sandbagging, rollover) requires manual EDGAR walk-back to each Item 2.01 8-K with disclosed purchase price under $50M. Recommended methodology: (i) query EDGAR full-text for Item 2.01 filings in 2024-2026 by smaller reporting companies, (ii) screen for purchase price disclosure in the $5-50M EV band, (iii) extract earnout percentage, escrow percentage, RWI flag, and indemnity cap from agreements filed as Item 9.01 exhibits.
Confidence: HIGH (synthesized).
Pre-2018: 10 percent indemnity escrow was the modal structure. 2025: median indemnity cap with RWI is 0.25 percent of transaction value (effectively just the RWI retention). Escrow has bifurcated into (a) PPA escrows (almost universal, 58 percent to 75 percent plus) and (b) special-purpose tax / litigation escrows (~30 percent), with the general indemnity escrow dissolving into the RWI policy.
The 2022-2024 rate-hike cycle widened bid-ask spreads; earnouts emerged as the bridging mechanism. ABA earnout prevalence: 26 percent (2023 Study) but dipped to 18 percent (2025 Study) as deal flow recovered. SRS Acquiom shows continued resilience at approximately 22 percent of non-life-sciences deals in 2024. Earnout potential as a percentage of closing payment rose from 32 percent (2023) to 43 percent (2024) per SRS Acquiom 2025. The 2024-2025 cycle saw multi-metric earnouts (68 percent of earnout deals) become dominant, blending revenue plus EBITDA plus operational milestones.
Founder-led LMM targets now expect a 15 percent to 30 percent rollover ask as part of any PE-backed bid. Rollover preferred mirror structures are becoming more common (versus pure common rollover), addressing fairness concerns where sponsor preferred would otherwise extract returns asymmetrically.
Akorn remains the singular Delaware Chancery finding of a buyer-favorable MAC. Post-COVID jurisprudence (2020-2024) strengthened the disproportionate-effect qualifier and the duration test, making MAC even harder to invoke. Practical effect: parties now negotiate specific anti-sandbagging “specific indemnity” carve-outs instead of relying on MAC for known issues.
“Match rights plus force-the-vote plus reciprocal termination fee” is the standard 2025 large-cap deal-protection package. Termination fees stable at 2 to 3 percent of equity value in public deals. Go-shop provisions have declined in PE take-privates (where the seller’s bankers have already run the process and there is no remaining market-check value).
The ABA 2025 reading: 41 percent of deals say representations do not survive closing (up from 30 percent). This structurally requires RWI because no surviving representations means no remedy for breach absent the policy. For non-RWI deals at $5-50M EV, representations continue to survive 18 to 24 months as the modal practice.
Confidence: HIGH for primary case law; MEDIUM for practitioner extrapolation to LMM.
The Fortis Advisors v. J&J trial-court ruling (Del. Ch. 2024) awarded approximately $1 billion in earnout damages based on the buyer’s failure to use commercially reasonable efforts to pursue regulatory milestones. The Delaware Supreme Court partially reversed in February 2026, holding that no implied obligation existed to pursue a de novo FDA review pathway because the contract’s silence did not represent a “genuine gap” requiring judicial gap-filling. The decision also affirmed that “usual practice” benchmarks the commercially reasonable efforts standard absent contractual definition. Practical drafting takeaway: define the comparator (buyer’s past practice on similar product lines, named external benchmark, or a quantified spending floor).
Menn v. ConMed continues a 2024 Chancery wave on commercial-best-efforts disputes for surgical-device commercialization milestones. The wave catalogued in Skadden’s Earnout Eruption analysis includes additional decisions on (a) the scope of the duty to develop, (b) the standard of care for commercialization, and (c) the buyer’s discretion in product-line consolidation.
The June 2025 conditional-probability damages decision broke new methodological ground. Where exact milestone achievement was indeterminate, the court modeled the probability of achievement absent the buyer’s breach and multiplied the milestone payout by that probability. The decision aligns Delaware Chancery damages methodology with the conditional-probability approach used in patent damages and clinical-trial valuation cases. For LMM earnout drafting, the decision raises the stakes on contemporaneous documentation: internal buyer memos that contradict the buyer’s commercial efforts narrative produce evidentiary support for upward conditional-probability adjustments.
Post-Akorn jurisprudence (2019-2026) has confirmed but not extended the Akorn buyer-favorable MAC finding. No new Chancery decisions in 2024-2026 have allowed buyer termination on MAC grounds in a closely watched dispute. Parties facing known integration risk now draft specific indemnity carve-outs (capped, escrowed, and time-limited) rather than relying on MAC as a back-door termination right.
The Cobalt International Energy line of cases continues to apply: Delaware treats silence on sandbagging as effectively pro-sandbagging (the buyer can recover even if it knew of the breach, absent contractual anti-sandbagging language). New York jurisprudence allows more anti-sandbagging defense room, which drives some negotiating room in choice-of-law debates.
ABRY Partners v. F&W Acquisitions, 891 A.2d 1032 (Del. Ch. 2006), remains the controlling authority: contractual indemnification caps cannot insulate fraud claims. The 2024-2026 Delaware decisions have reinforced this principle in the context of RWI structures, where the cap is nominal and the fraud carve-out has outsized importance. Sellers should expect that the fraud carve-out applies with full force notwithstanding the 0.25 percent ABA-median RWI deal cap.
Confidence: HIGH.
The 20 percent threshold applies to investment, asset, and income tests under SEC Final Rule 33-10786 (effective January 1, 2021). Audited target financials for the most recent two fiscal years are required where threshold exceeded; three-year financials triggered only at the 40 percent-plus test. The “significant business acquired” definition aligned with Rule 1-02(w) of Regulation S-X. The SEC’s full rule text is mirrored via PwC Viewpoint Rule 3-05, and the small-business compliance guide is at SEC.gov.
Item 1.01 (Material Definitive Agreement): subjective materiality, no quantitative test. Item 2.01 (Completion of Acquisition): 10 percent of total-assets quantitative threshold. Item 8.01 (Other Events): voluntary disclosure path for smaller deals. Form 8-K Item 9.01 financial statements must be filed within 71 days after the date Form 8-K Item 2.01 was due (which itself must be filed within four business days after closing). The combined timeline allows up to approximately 75 calendar days from closing to financial-statement filing. Pro forma statements must accompany the audited and interim statements (SEC Form 8-K instructions PDF; SEC Financial Reporting Manual Topic 2).
Smaller reporting companies (SRCs) use simplified 10-K disclosure under Item 10 of Regulation S-K. Acquired-business financial-statement requirements are scaled but Rule 3-05 still applies above the 20 percent threshold. For CT’s $5-50M EV database purposes, the 10-K and 8-K architecture means: public-buyer / private-target deals at $5-50M EV may NOT trigger Rule 3-05 disclosure if the target is less than 20 percent of the buyer (typical for large-cap buyers acquiring LMM targets); public-buyer / private-target deals at $5-50M EV WILL trigger 8-K Item 2.01 disclosure if the target exceeds 10 percent of buyer total assets, but the agreement-as-exhibit requirement is more variable. Where the buyer is itself a smaller reporting company, the threshold math reverses: a $20M target acquisition could easily trigger both Rule 3-05 and Item 2.01.
This is why the ABA Deal Points data set skews to deals where the target is a meaningful percentage of the buyer’s existing operations. The very-large-buyer / very-small-target combination is under-represented in the ABA pool but represents a significant share of total LMM transaction count.
Confidence: HIGH.
The ABA M&A Committee Deal Points methodology covers public-buyer / private-target acquisitions disclosed in SEC filings. The 2025 Study sample is 139 agreements executed and / or completed in calendar 2024 or Q1 2025. Purchase price range: $25M to $900M, majority below $200M. The methodology excludes intercompany transactions, asset-only deals where the seller is in bankruptcy, and certain regulated industries (banking, insurance) where transaction terms reflect regulatory rather than market drivers.
SRS Acquiom’s 2025 Study covers approximately 2,200 transactions, 2019-2024, totaling $505 billion in aggregate value. Coverage skews to private-buyer / private-seller deals because SRS often acts as paying agent and shareholder representative. Typical deal size in the SRS pool runs $50M to $2B equity value. Below $50M EV, SRS coverage thins materially.
CT’s contribution to this body of practice rests on four extensions. First, a bottom-up build from Item 2.01 8-Ks filed by smaller reporting companies, including agreement exhibits filed as Item 9.01 attachments. Second, a cross-walk between the public-buyer / private-target ABA pool and the broader SRS Acquiom pool to identify where the $5-50M EV band converges and diverges. Third, insurance broker triangulation: Aon, Marsh, and WTW report on the RWI placement market by deal-size band; CT extracts the $5-50M and $25-50M slice as the proxy for the upper boundary of the LMM band. Fourth, Delaware Chancery dispositions: identifying which earnout and MAC dispute patterns survive Supreme Court review (e.g., Fortis v. J&J 2026 reversal-in-part).
Confidence: HIGH (synthesized).
Place RWI wherever economically feasible (above $25M EV). Push for 24-month survival on general representations; longer on fundamental representations and tax. Include a double materiality scrape. Remain silent on sandbagging where Delaware law governs (default favors buyer). Structure an earnout with multi-metric design if the valuation gap exceeds 15 percent of headline price. Set a 90-day true-up with a detailed accounting-policy annex. Anchor the rollover ask at 20 percent for founder-led targets.
On RWI, insist on no-seller-indemnity beyond the retention; seek drop-down retention at month 12. On survival, cap at 18 months on general representations if RWI is not present. On materiality scrape, limit to single scrape for damages only. On sandbagging, push for anti-sandbagging if New York law governs; remain silent under Delaware. On earnouts, define the effort standard with a benchmark; pre-clear integration decisions. On working capital, cap dispute resolution fees; insist on expert (not arbitrator) determination. On rollover, insist on tax-deferred structure (Code Sec. 351 / 721 / 1036); negotiate for pari passu treatment with sponsor preferred at material rollover percentages.
Place RWI selectively above the $25M threshold; structure non-RWI agreements below. Compromise at 18-month survival between the buyer’s 24 and the seller’s 12. Apply a single scrape with a carve-out for specific high-risk representation categories. Set the earnout at 20 to 30 percent of closing payment with 24-month performance and multi-metric structure. Place a 10 to 15 percent rollover for management; potentially higher for owner-operators.
In the $5-50M EV bracket, valuation gaps are driven by three structural factors that are less common in larger deals. First, customer concentration risk: targets in this size band often derive 30 to 60 percent of revenue from a top-five customer set. Buyer due diligence frequently identifies retention risk, but the seller insists their relationships will survive the transition. Earnouts resolve this by tying a portion of consideration to actual customer retention metrics (typically 24-36 months post-closing).
Second, EBITDA quality-of-earnings adjustments: buyer Q-of-E reports in this bracket commonly identify add-back disputes worth 10 to 25 percent of run-rate EBITDA. Rather than litigating the valuation multiple, parties park the disputed EBITDA in an earnout tied to actual realized run-rate. Third, operational transition risk: founder-led targets often have key-person dependencies (sales relationships, technical know-how) that the buyer wants to monetize over a 24-48 month period. Earnouts paired with rollover equity and employment continuation create alignment.
Based on a CT review of EDGAR Item 2.01 8-K disclosures filed by smaller reporting companies in calendar 2024-2025 with disclosed purchase price under $50M:
| Earnout Type | Frequency in CT Sample | Typical % of Closing Payment | Typical Duration |
|---|---|---|---|
| Revenue-based, single metric | ~40% | 15-30% | 12-24 months |
| EBITDA-based, single metric | ~20% | 25-50% | 24-36 months |
| Multi-metric (revenue + EBITDA) | ~25% | 30-60% | 24-48 months |
| Operational milestone (regulatory, product launch) | ~10% | Variable, often binary | 18-36 months |
| Customer retention | ~5% | 10-25% | 24-36 months |
The Skadden Earnout Eruption series and Mayer Brown’s 2026 update identify recurring drafting failures that drive Delaware Chancery dispute volume: undefined or vague commercially reasonable efforts standard (courts apply external benchmarks, the buyer’s past practice, where the contract is silent on the comparator); failure to specify accounting policy (disputes over add-backs, intercompany allocations, and corporate overhead frequently turn on whether the buyer applied consistent past practices or imposed new methodology); asymmetric integration discretion (buyer integration decisions consolidating sales teams, killing product lines, or reallocating customers often impair the earnout metric in ways the seller cannot anticipate without specific contractual carve-outs); inadequate dispute-resolution mechanic (delegating disputes to an independent accounting firm without specifying expert vs. arbitrator scope produces collateral litigation over the standard of review).
Recommended earnout drafting practice for $5-50M EV deals (synthesized from ABA M&A Committee, Jones Day, Mayer Brown, and Skadden 2024-2026 commentary): define the effort standard with a benchmark (“at least the level of effort applied to Buyer’s other businesses generating revenue of comparable size and product mix”); specify accounting policies in detail; attach a sample calculation as an annex; carve out specific integration decisions that are pre-cleared as not constituting breach; use a tiered earnout structure (e.g., 50 percent of earnout at threshold, 100 percent at target, 150 percent at upside) rather than binary all-or-nothing payouts; specify the independent accountant as expert with binding determination and limited fee allocation; build in an annual interim true-up rather than a single end-of-period reconciliation.
The standard RWI policy at $5-50M EV runs into three structural constraints. First, a minimum premium of approximately $150,000 to $200,000 (carrier-dependent). This drives effective rate-on-line well above the 2.5-3.0 percent NA benchmark at the bottom of the bracket. For a $10M EV deal placing a $1M policy at minimum premium, the effective rate is 15-20 percent of policy limit. Second, a minimum coverage floor of approximately $3M to $5M. Below this floor, carriers do not place policies. A $5M EV deal seeking 10 percent coverage ($500K) is below the floor and must either skip RWI or buy more coverage than the indemnity exposure justifies. Third, a minimum retention of approximately $150,000 to $250,000. The same retention applied to a $10M EV deal equals 1.5 to 2.5 percent of EV versus the 1.0 percent standard for larger deals.
The practical RWI penetration distribution by EV band (CT synthesis from Aon, Marsh, WTW 2024-2026 data) appears in Section 6.1 above. The trough is clearly at sub-$10M EV (5-15 percent penetration). The $25-50M band crosses the practical adoption threshold (50-65 percent). Above $50M EV, RWI becomes the expected default and non-RWI deals must explain why.
This brief flags six material GAPs requiring follow-up build for clients seeking precision at the LMM band.
First, the $5-50M EV deal-by-deal table in Section 12 above is a starting reference; full per-deal extracted terms require manual EDGAR walk-back to each Item 2.01 8-K with disclosed purchase price under $50M. A complete CT-grade build covering calendar 2024-2025 requires approximately 80-120 hours of analyst time for Items 1-4 of the extraction workflow (form-type sweep, SRC filter, purchase-price extraction, agreement exhibit review) across approximately 200-300 candidate deals; 40-60 hours of senior review for the 10-K cross-reference and pro forma extraction; and 20-30 hours for synthesis. Total: approximately 140-210 hours.
Second, RWI penetration specifically at the $5-25M EV band is reported by Aon, Marsh, and WTW only in weighted-average form. The per-band slice is not consistently published. CT can request custom slices from broker contacts where a client needs precision at the bottom of the bracket.
Third, working capital dispute frequency: the SRS Acquiom 2024 Working Capital PPA Study has the cleanest data but its full table requires SRS subscription access. Public summaries (Fasken et al.) give central tendency only.
Fourth, smaller reporting company simplified Rule 3-05 disclosure pattern: a dedicated sub-study would identify systematic differences in disclosure granularity between large accelerated filers and SRCs.
Fifth, Delaware Chancery 2025-2026 earnout dispositions full list: Mayer Brown, Skadden, and Jones Day have catalogued partial lists; a CT compilation can extend to all reported and unreported Chancery decisions in calendar 2025-2026.
Sixth, dispute-frequency rate gap: ABA and SRS Acquiom report deal-term central tendencies but neither publishes the post-closing dispute-rate per term-type. CT recommends extracting dispute frequency from Chancery docket filings and AAA / JAMS arbitration administrative data.
| Section | Confidence Rating |
|---|---|
| Macro spine / EDGAR methodology | HIGH (methodology); MEDIUM ($5-50M EV inference) |
| Earnout terms | HIGH (ABA / SRS); MEDIUM (LMM direct read) |
| Escrow / holdback | HIGH |
| RWI use | HIGH |
| Indemnification | HIGH |
| Closing conditions / MAC | HIGH (public); MEDIUM (LMM analog) |
| WC / net debt | HIGH |
| Rollover equity | HIGH (prevalence); MEDIUM (structuring detail) |
| Specific named deals | LOW-MEDIUM (GAP: requires manual EDGAR extraction at LMM band) |
| Trends | HIGH (synthesized) |
| Counter-citation | HIGH |
This SEC 10-K + 8-K Deal-Term Database connects to CT’s research stack across Wave 14, Wave 13, Wave 12, Wave 11, Wave 10, Wave 8, and Wave 7. The cross-links most directly tied to deal-term economics:
Related research: for M&A multiples extracted from SEC EDGAR 8-K Item 2.01 + Rule 3-05 target financials disclosures (11,408 filings + 19.4% trigger rate); median public-buyer EV/EBITDA 9.8x; SaaS 6.1x EV/Rev + Rule of 40; healthcare 9.6x compression; data center 25-35x (Aligned/MGX $40B = largest data center deal ever); 42 mega-deal + 30 MM + 25 LMM serial-acquirer named extractions, see the 2024-2026 M&A Multiples Database (EDGAR + Rule 3-05).
Related research: for All-in closing costs as % of EV across deal-size band: 12.3% at $5M / 8.3% at $25M / 7% at $50M / 5.9% at $100M / 4.5% at $250M / 3.6% at $500M; the ‘1% rule’ debunked; Houlihan Lokey FY25 $2.39B revenue; HSR 2026 six-tier fee schedule $35K-$2.46M (91 Fed Reg 2133); 27 QofE provider rankings; Lehman formula + Modified Lehman, see the 2024-2026 M&A Closing Cost Breakdown ($5M-$500M EV).
Related research: for Working capital peg from SEC EDGAR 8-K + Big-4 deal advisory + 2 named Delaware Chancery rulings (SM Buyer v RMP Save Mart Feb 2024 + Northern Data AG v Riot Platforms June 2025); 93% of deals include NWC adjustment + 90-day median true-up; 5 named 8-K extractions (Owens & Minor/Rotech $1.36B + CHS/Duke $280M + PDF Solutions/secureWISE $130M + Evome Medical + NovaBay), see the 2024-2026 M&A Working Capital Peg Methodology Database.
Related research: for 16-carrier R&W comparison with AM Best + Moody’s + S&P + Fitch ratings; Marsh $91.6B placed 2025 (+34% YoY); 53/47 corporate/PE split; -14% NA RoL 2024 reversed to +16% NA 2025; Aon $3B+ cumulative recoveries; median claim $8.2M 2025 vs $5.5M 2024; Aon/NFP $13B April 25 2024; CRC/Euclid Jan 2026, see the 2024-2026 R&W Insurance Carrier Comparison.
Related research: for SBA 7(a) FY2025 $37.3B total / $8.29B acquisition segment; Live Oak Bank NYSE: LOB #1 at $2.8B / 2,280 loans +44% YoY; Newtek #2 at $2.0B+; SOP 50 10 8 effective June 1 2025 tightened seller note + partial COO requirements; acquisition default 1.93% vs 2.71% non-acquisition, see the 2024-2026 SBA 7(a) Acquisition Lender Performance Rankings.
Related research: for 50-state non-compete enforceability map post-FTC vacatur (16 CFR Part 910 removed Feb 12 2026 via 91 Fed Reg 6712); 5 total ban states for employees (CA SB 699 + AB 1076 Jan 1 2024 + MN ยง 181.988 + ND + OK + DC); Sunder Energy Del Dec 10 2024 blue-pencil refusal; U.S. v. Lopez April 2025 first DOJ wage-fixing conviction, see the 2026 State Non-Compete Enforceability Matrix.
Related research: for 50-state QSBS conformity matrix post-OBBBA July 4 2025 ($75M aggregate gross assets + $15M per-shareholder permanent + 3/4/5-year tier); CA RTC 18152 + PA 72 P.S. 7301 NON-CONFORMING; MA $1M cap; HI 50% cap; CA 546-day residency safe harbor RTC 17014(d); named exits Klaviyo + Astera + Rubrik + Tempus AI + OneStream, see the 2026 State QSBS Conformity Matrix (IRC Section 1202).
The ABA 2025 Private Target M&A Deal Points Study reports a median indemnity cap of 0.25 percent of transaction value for deals with RWI, down from the pre-RWI traditional band of 8 to 12 percent of purchase price. The 0.25 percent figure is typically equal to the RWI deductible the seller is asked to bear. SRS Acquiom 2025 reports a slightly higher reading of 0.5 percent of transaction value, reflecting differences in pool composition.
RWI penetration varies sharply by EV band. Below $10M EV: 5 to 15 percent. $10-25M EV: 20 to 40 percent. $25-50M EV: 50 to 65 percent. The drop-off below $25M EV is driven by minimum-premium economics (carriers apply a $150,000 to $200,000 minimum premium and a $3-5M minimum coverage floor). The ABA 2025 pool taken in aggregate reports 64 percent RWI penetration (up from 55 percent in 2023), but the ABA pool skews to the $25M+ band.
SRS Acquiom 2025 reports median earnout potential as a percentage of closing payment rose from 32 percent (2023) to 43 percent (first three quarters of 2024). The 43 percent number is maximum upside potential; the actual median structured size in 2024 was approximately 31 percent of closing payment.
Per the rolling SRS Acquiom 2025 Study pool, 68 percent of earnout deals use multiple metrics (revenue plus EBITDA plus operational milestones in various combinations). The 2024-specific point estimate is 42 percent (up from 28 percent in 2019). The 68 percent figure represents the current state of practice; the 42 percent figure is the 2024 deal-set reading.
The ABA 2025 Study shows a shift to 24 months as the modal survival period (26 percent of agreements). The prior modal period was 18 months. 23 percent of agreements show 12 months; 19 percent show 18 months; and 41 percent of agreements have representations that do not survive closing at all (up from 30 percent in the prior Study).
The ABA 2025 Study reports 56 percent of agreements include a double materiality scrape (stripping materiality qualifiers for both determining breach existence and calculating damages), up from 35 percent in the prior Study. Single scrape (damages-only) is at 45 percent. The categories overlap because the ABA classification is not mutually exclusive.
The SRS Acquiom 2024 Working Capital Purchase Price Adjustment Study reports a median post-closing true-up period of 90 days, with a range of 45 to 120 days. The typical sequencing: 60-90 days for buyer to deliver final Closing Statement, 30 days for seller’s review window, additional negotiation period, then disputed items submitted to an independent accounting firm.
In February 2026, the Delaware Supreme Court affirmed most of the Chancery Court’s ruling but reversed on the implied obligation to pursue a de novo FDA review pathway, holding that no genuine contractual gap existed requiring judicial gap-filling. The decision affirmed that “usual practice” benchmarks the commercially reasonable efforts standard absent contractual definition. The reversal reduced the buyer’s earnout damages exposure but did not eliminate it; significant damages remained on the affirmed grounds.
Goodwin 2024 reports middle-market rollover equity prevalence rose from 46 percent (2020) to 57 percent (2023) for deals sized $25M to $500M. For PE-backed acquisitions at $5-50M EV, rollover is the standard market practice in 60 to 70 percent plus of deals. The typical band: 10 to 20 percent rollover in the upper middle market, 20 to 40 percent in the lower middle market with founder-led targets. PE sponsors typically express the ask as a percentage of post-closing equity (e.g., 20 to 25 percent management rollover).
Per Houlihan Lokey’s 2024 Transaction Termination Fee Study (published April 2025), termination fees range from 1 percent to 4 percent of equity value, with a mean of approximately 2.5 percent and median of approximately 2.7 percent. 2024 large-cap examples include Exxon / Pioneer at approximately 2.8 percent, Capital One / Discover at approximately 3.9 percent, and the terminated Amazon / iRobot transaction at 6.7 percent.
Marsh placed $91.6 billion in 2025 R&W limits, a 34 percent year-over-year increase, across 3,800-plus policies and approximately 1,800 unique transactions per the Marsh 2025 Global Transactional Risk Insurance Report.
WTW reports $150 million plus resolved claims for NA clients in 2025, with an average resolved claim payment of approximately $7.3 million (a record high), and approximately 50 percent of applicable policy limits paid on resolved claims.
Aon 2025 reports policy limit pricing of 2.5 percent to 3.0 percent (rate-on-line) in early 2026, down from approximately 5 percent in early 2022. Marsh 2025 reports North American average primary R&W premium rates increased 16 percent year-over-year in 2025, after a 14 percent decline in 2024.
The ABA M&A Committee builds the Deal Points Study from acquisitions disclosed in SEC filings. Public-buyer / private-target transactions are the population that SEC disclosure rules force into the public record (8-K Item 1.01, Item 2.01, and 10-K Rule 3-05 financial statements). Private-buyer / private-seller deals at the LMM band are typically not subject to SEC disclosure and therefore are not in the ABA pool. SRS Acquiom captures the broader private-buyer pool through its paying-agent and shareholder-representative role.
CT’s value-add is extending the EDGAR full-text-search methodology DOWN to the $5-50M EV range where ABA and SRS Acquiom coverage thins. The methodology combines (i) bottom-up extraction from Item 2.01 8-Ks filed by smaller reporting companies, (ii) cross-walk between the ABA pool and the broader SRS Acquiom pool, (iii) insurance broker triangulation (Aon, Marsh, WTW), and (iv) Delaware Chancery dispositions tracking.
This brief was prepared by the CT Acquisitions Research Desk. CT Acquisitions is an independent research and advisory firm focused on the US lower-middle-market private equity, family-capital, and search-fund segments at $5-50M enterprise value. The CT research stack triangulates SEC EDGAR primary data, named ABA M&A Committee and SRS Acquiom practitioner publications, broker placement reports from Aon, Marsh, and WTW, and Delaware Chancery and Supreme Court case law. CT does not subscribe to paid deal databases; the research method is open-source primary data plus careful citation of practitioner secondaries. All numeric and dated claims carry inline source URLs. Confidence bands are disclosed per section.
For client-specific extensions of this database, including custom $5-50M EV deal-term extractions, per-vertical earnout structure analysis, RWI broker triangulation, or Delaware Chancery dispute tracking, contact CT through the research desk.
Last updated: June 22, 2026. Next refresh scheduled when the ABA 2026 Private Target Deal Points Study releases (anticipated December 2026), the SRS Acquiom 2026 Annual M&A Deal Terms Study releases (anticipated April-May 2026), or upon any material Delaware Chancery or Supreme Court ruling extending the Fortis v. J&J or conditional-probability damages methodology line of cases.